Dumitru
Mişcalencu, Lăcrămioara Ivanciu, Florica Mailat, Cristina
Bordea, Oncogene virale |
1.
Souyri M., 2. Kinsella
A. R., Fiszer-Maliszewska L., Mitchel E., Guo Y. P., Fox M., Scott O.,
Introduction of the activated N-ras oncogene into human fibroblasts by
retroviral vector induces morphological transformation and tumorogenity. Carcinogenesis, 1990, 10, 1803–1809. 3.
Hamburger V., Logsiffoul A., Bockaert J., Grandes et petites proteins G dans
trafic vesiculaire. Annales d’Endocrinologie (Paris), 1996, 57, 83-90. 4. Shields
J. M., Rogers-Graham K., Der C. J., Loss of transgelin in breast and colon
tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-1
independent pathways. J. Biol. Chem. 2001 Dec.28. 5. Stacey
D., Kazlauskas A., Regulation of Ras signaling by the cell cycle. Curr. Opin.
Genet. Dev. 2002, 12(1), 44–6. 6. Park T.
J., Han S.U., Cho Y. K., Paik W. K., Kim Y. B., Lim I. K., Methylation of
O(6)-methylguanine-DNA methyltransferase gene is associated significantly with
K-ras mutation, lymph node invasion, tumor staging, and disease free survival
in patients with gastric carcinoma.Cancer, 2001, 92(11), 2760-8. 7.
Alguacil J., Porta M., Malats N., Kauppinen T., Kogevinas M., Benavides F. G.,
Partanen T., Carrato A., Occupational
exposure to organic solvents and K-ras mutations in exocrine pancreatic
cancer. Carcinogenesis, 2002, 23(1),
101-106. 8. Lu X.,
Xu T., Qian J., An application value of detecting K-ras and p53 gene mutation
in the stool and pure pancreatic juice for
diagnosis of early pancreatic cancer. Zhonghua Yi Xue Za Zhi, 2001, 81(17),
1050-3. 9. Hiyama
T., Haruma K., Kitadai Y., Masuda H., Miyamoto M., Tanaka S., Yoshihara M.,
Shimamoto F., Chayama K., K-ras mutation in helicobacter pylori-associated
chronic gastritis in patients with and without gastric cancer. Int. J. Cancer, 2002, 97(5), 562-6. 10. Fisher G. H., Wellen S. L., Klimstra D.,
Lenczowski J. M., Tichelaar J. W., Lizak M. J., Whitsett J. A., Koretsky A,
Varmus HE. Induction and apoptotic
regression of lung adenocarcinomas by regulation of a K-Ras transgene in the
presence and absence of tumor suppressor genes. Genes Dev., 2001, 15(24),
3249-62. 11. Jackson E. L., Willis N., Mercer K., Bronson
R. T., Crowley D., Montoya R., Jacks T., Tuveson D. A., Analysis of lung tumor initiation and
progression using conditional expression of oncogenic K-ras. Genes Dev., 2001, 15(24), 3243-8. 12. Kato K., Horiuchi S., Takahashi A., Ueoka Y.,
Arima T., Matsuda T., Kato H., Nishida J. J., Nakabeppu Y., Wake N.,
Contribution of estrogen receptora (Era) to oncogenic K-Ras-mediated NIH3T3
cell transformation and its implication for escape from senescence by
modulating the p53 pathway. J. Biol. Chem., 2002 Jan 7. 13. Zhu S., Yoon K., Sterneck E., JohnsonP. F., Smart R.C., CCAAT/enhancer binding
protein-beta is a mediator of keratinocyte survival and skin tumorigenesis
involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. USA, 2002, 99(1),
207-212. 14. Zacharatos P., Kotsinas A., Tsantoulis P.,
Evangelou K., Kletsas D., Asimacopoulos P. J., Doussis-Anagnostopoulou I.,
Pezzella F., Gatter K., Papavassiliou A. G., Kittas C., Gorgoulis V. G., Relationship of the K-ras/c-mos expression
patterns with angiogenesis in non-small cell lung carcinomas.Mol. Med., 2001, 7(9), 590-7. 15. Breier G., Blum S., Peli J., Groot M., Wild
C., Risau W., Reichmann E., Transforming growth factor- beta and Ras regulate
the VEGF/VEGF-receptor system during tumor angiogenesis. Int. J. Canecer, 2002,
97(2), 142-8. 16. Janda E., Lehmann K., Killisch I., Jechlinger
M., Herzig M., Downward J., Beug H., Grunert S., Ras and TGF(beta)
cooperatively regulate epithelial cell plasticity and metastasis: dissection of
Ras signaling pathways. J. Cell. Biol. 2002, 156(2), 299-314. 17. Zhou M., Horita D. A., Waugh D. S., Byrd R.
A., Marrison D. K., Solution Structure and Functional Analysis of the
Cysteine-rich C1 Domain of Kinase Suppressor of Ras (KSR). J. Mol. Biol. 2002,
315(3), 435-46. 18. Wang Y., Waldron R. T., Dhaka A., Patel A.,
Riley M. M., Rozengurt E., Colicelli J., The RAS effector RINI directly
competes with RAF and is regulated by 14-3-3 proteins. Mol. Cell. Biol. 2002, 22(3), 916-26. 19. Wessler S., Rapp U. R., Wiedenmann B., Meyer
T. F., Schoneberg T., Hocker M., Naumann M., B-Raf/Rap1 signaling, but not
c-Raf-1/Ras, induces the histidine decarboxylase promoter in Helicobacter
pylori infection. FASEB J. 2002 Jan. 14. 20. Colombo L.
L., Lopez M. C., Chen G., Watson R. R., In vitro response of v-Ha-ras
transgenic mouse lymphocytes after in vivo treatment with cocaine.
Immunopharmacol. Immunotoxicol. 2001, 23(4), 607-16. 21. Colombo L.
L., Lopez M. C., Chen G., Watson R. R., In vitro response of v-Ha-ras
transgenic mouse lympho-cytes after in vivo treatment with alcohol.Immunopharmacol. Immunotoxicol. 2001, 23(4),
597-606. 22. Chakravarti D., Mailander P. C., Li K. M.,
Higginbotham S., Zhang H. L., Gross M. L., Meza J. L., Cavalieri EL, Rogan EG.
Evidence that a burst of DNA depurination in SENCAR mouse skin induces error -
prone repair and forms mutations in the H-ras gene. Oncogene, 2001, 20(55),
7945-53. 23. Yan Z., Kim G. Y., Deng X., Friedman E.,
TGF(beta)1 induces proliferation in colon carcinom cells by Ras-dependent,
Smad-independent downregulationof
p21cip1. J. Biol. Chem. 2002 Jan 9. 24. Sheta E. A., Trout H., Gildea J. J., Harding
M. A., Theodorescu D., Cell density mediated pericellular hypoxia leads to
induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling
pathways. Oncogene, 2001, 20(52), 7624-34. |
© University of Bucharest 2002. All rights reserved. |
||
No part of this text may be reproduced in any form without written permission of the University of Bucharest, except for short quotations with the indication of the website address and the web page. Comments
to: Dumitru
Mişcalencu, Lăcrămioara Ivanciu, Florica Mailat, Cristina
Bordea |